Correspondence

Further advice on U-47,700, etizolam and other designer benzodiazepines

Further letter from the Advisory Council on the Misuse of Drugs about U-47,700 and designer benzodiazepines.

Documents

Response from Sarah Newton: further advice on U-47,700 and designer benzodiazepines

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Addendum to advice on U-47,700, etizolam and other designer benzodiazepines

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The chair of the ACMD, Les Iversen, replies to Minister for Vulnerability, Safeguarding and Countering Extremism Sarah Newton about:

  • the opioid U-47,700
  • designer benzodiazepines

Read the ACMD’s original advice and Sarah Newton’s response.

Published 22 December 2016
Last updated 10 March 2017 + show all updates
  1. Published addendum on U-47,700, etizolam and other designer benzodiazepines.
  2. Added the latest response from Sarah Newton
  3. First published.